Immune checkpoints, exemplified by the PD-1/PD-L1 axis, are strategically positioned within the tumor microenvironment and lymphoid organs, providing cancer cells the means to co-opt these checkpoints and dampen anti-tumor immune responses [47,48]. Here, CD274 is linked to cancer.